Home » Newsletters » BioWorld Science

BioWorld Science

July 10, 2000

View Archived Issues

AVI BioPharma to receive two grants to fund NeuGene antisense program

DuPont and Emisphere reach agreement on oral heparins

Aquila enters licensing agreement with Beth Israel for immune system-enhancing antibodies

Tamoxifen for DCIS granted FDA approval

Piboserod inhibits increased defecation under stress in preclinical study

Cel-Sci's Multikine improves cell-mediated immunity in HIV-infected patients

Amarillo Biosciences and Hayashibara to develop inhalable interferon gamma

JTV-519 improves contractile recovery after ischemia-reperfusion

FDA authorizes HemispheRx Biopharma trial for multidrug-resistant HIV

Positive results reported by Biovector from second phase I trial of nasal flu vaccine

Abbott licenses novel antimitotic agent from Eisai

Efficacy of FK-463 in disseminated azole-resistant candidiasis in mice

Aronex files NDA amendment for Atragen as treatment for APL

SkyePharma grants Paladin exclusive Canadian rights for DepoCyt

First step in the development of a probe for monitoring, diagnosing AD in living patients

Chimeric peptide exerts analgesic effects without tolerance development

Chronic AF-150(S) associated with cognitive and behavioral improvement in aged primate model

CPMP grants positive opinion for Actos as treatment of type 2 diabetes

Role for raloxifene in postmenopausal women with Alzheimer's disease

Effects of AWD-12-281 in preclinical models of asthma and COPD reported in Lisbon

Inhibition of peptido-leukotrienes by olopatadine may account for antiallergic effects

Herbal medicine modulates cytokine production and ameliorates ConA-induced hepatitis

SmithKline presents new tachykinin receptor antagonists, their synthesis and use

CCR3 receptor antagonists from Roche reportedly useful in asthma

Merck KGaA describes new series of compounds for thrombotic disorders

New inhibitors of Abeta production patented by Takeda

Schering-Plough patents new group of vitronectin receptor antagonists

Potent dopamine D2 receptor antagonists designed by Pierre Fabre for use in schizophrenia

Anticoagulant 2-pyridones under study at Sanofi-Synthelabo

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Sun Pharma to acquire Merck spinoff Organon for $11.75B
BioWorld
Sun Pharmaceuticals Industries Ltd. will pay $11.75 billion cash to acquire Organon & Co. The transaction is expected to close in early 2027. The addition of...